All Grants

American College of Cardiology Foundation Young Investigator Awards Competition

The Young Investigator Awards competition encourages and recognizes young scientific investigators of promise, upon whom progress in the field of cardiology is dependent. A manuscript and abstract summarizing any problem that relates to cardiovascular disease whether it be in etiology, pathophysiology, diagnosis, or therapy.

Award Categories include the following:

1. ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology

2. Physiology, Pharmacology and Pathology

3. Clinical Investigations, Congenital Heart Disease and Cardiac Surgery

4.Cardiovascular Health Outcomes and Population Genetics

*Doctorate level nurses, physician assistants and clinical pharmacists in research are strongly encouraged to apply in this category

Eligibility: Physicians, scientists, medical students, and other healthcare providers currently in residency or fellowship programs, or are no more than three years out of training. PhD, PharmD or DNP candidates who are no more than three years out of training may also apply.    

Note: Candidates will be eligible for this award up to four years after completion of training if more than three months of family or sick leave was taken during training or in the first three years after completion of training.

The Award: The first place winner for each category receives $2,000, second place winners receive $1,000; three honorable mentions in each category receive $500. Travel, hotel and meals up to $1,500 will be reimbursed for all 20 finalists to attend the YIA Competition at ACC.14 in Washington, DC.

Funding Source: Support for the ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology is provided by a grant from CV Path Institute and the family of Herman K. Gold.

Deadline: October 11, 2013

For more information: Email Kristin Robertson or call 800-253-4636, ext. 6390.

2014 Family Medicine Cares Resident Service Award

This service award requires that the resident identify an unmet health care need in his/her community. The resident will then design an innovative service project at a free health clinic (or similar health care facility) to address that unmet health care need and will implement the project for 12 months. The project should enhance the services offered by the free health clinic and have relevance to the patient population being served.

In designing the project, emphasis should be placed on activities that will have an enduring benefit to the patients and the community after the 12-month project period. Projects that can be continued or replicated by other family medicine residents in the future are also encouraged.

Note: It may be helpful to obtain input from the clinic’s staff when designing the project.

Eligibility

All first-year and second-year family medicine residents who are members of the American Academy of Family Physicians (AAFP) are eligible to apply. All applicants must still be residents when the project period ends.

Project Period

The project period will be May 1, 2014 to April 30, 2015.

Award

One award will be provided annually. The award will total $16,500 and contain the following elements:

• A $10,000 award will be provided to the resident whose service project is selected for funding. This funding is to be used by the resident only for costs directly related to the project. These may include: medical supplies (e.g., diabetes testing), equipment rental or purchase, software purchase or lease, patient education materials, communication expenses (e.g., postage, printing, office supplies), patient incentives/reimbursement, mileage/transportation (e.g., resident mileage), patient reimbursement, personnel not employed by free clinic or health care facility (e.g., patient educators, substance abuse or peer counselors).

• $5,000 award will be provided to the free clinic (or similar health care facility) where the service project is implemented. 

• $1,000 travel award will be provided to the resident to attend the 2015 National Conference (NC) of Family Medicine Residents and Medical Students. The resident will present the results of the project at this conference. 

• $500 stipend will be given to the residency program to celebrate and recognize the resident who wins the Family Medicine Cares Resident Service Award.

Required of Resident

The resident is required to submit the following reports:

• An interim financial report and progress report that highlights the service project activities and progress is required by November 1, 2014.

• A final financial report and final project summary detailing the implemented service project and its outcomes must be submitted by June 1, 2015.

• The resident will attend the 2015 National Conference (NC) of Medicine Residents and Medical Students to give a presentation on his/her project. Note: Registration fees for the NC will be waived for speakers.

Required Report from Clinic

The free clinic (or similar health care facility) is required to submit documentation six months after the resident’s project begins describing how the $5,000 award to the clinic is being utilized.

Letters of Recommendation/Support

Three letters are required to be submitted with the application:

• One letter of recommendation from the resident’s residency director 

• One letter of support from the director of the free clinic (or other health care facility) 

• One letter from the mentor (clinic director or other physician) agreeing to assist with the project should the award be granted

Deadline

The deadline for the application is February 1, 2014.

Award Announcement

The winner of the Resident Service Award will be announced by April 1, 2014.

Dissemination of Award

The $10,000 award for the resident will be distributed in three payments:

• $6,000 will be provided at the start of the project

• $2,000 will be provided after receipt of the interim reports

• $2,000 will be provided after receipt of the final reports

The $5,000 award for the free clinic will be distributed in two payments:

• $2,500 will be provided at the start of the project

• $2,500 will be provided after receipt of the clinic’s report six months after the project begins

The $500 stipend for the residency will be distributed when the award is announced.

How to Submit Your Application

All materials should be emailed and the original mailed (postmarked) no later than February 1, 2014 to: Susie Morantz, 11400 Tomahawk Creek Parkway, Suite 440, Leawood, KS 66211.

Questions

If you have any questions please feel free to email or call Susie Morantz at 800-274-2237, ext. 4470.

ALS Therapy Alliance Grants Program

Thank you for your interest in submitting a proposal for grant funding to the ALS Therapy Alliance (ATA). Our organization traditionally awards grants from one to three years in term ranging from $100,000 to $1 million in funding to both non- and for-profit companies. National and international companies are eligible to apply.

The following outline will help you prepare the information needed for our next funding review, which happens twice a year in April and November.

Please note grant submission deadlines and number of copies requested in order to ensure timely processing of your application. The ALS Therapy Alliance does not cover indirect costs.

If you have questions about the submission process or this application, please contact Ray Bisson, Grants Manager at (603) 664-5005 or ray@alstherapyalliance.org, or visit our FAQ page.

http://alstherapyalliance.org/index.php/research/grant-submission-process/faqs.html

What to include with your grant proposal

ATA grant applications should follow the following format and adhere strictly to the maximum page limits (using only 11 point font or greater):

■ Abstract (1 page)

■ Background and Significance (2 pages)

■ Preliminary Data (2 pages)

■ Experimental Plan (3 pages)

■ References (no limit)

■ Budget

■ Budget Justification

■ NIH Biosketch (including present and pending support, 4 pages maximum) for PI's, post-docs and others involved in the project (excluding laboratory technicians)

■ Letters of collaboration and support

Grant proposal submission deadlines

To have your grant proposal reviewed at our April meeting, please submit by March 15th. To have your grant proposal reviewed at our November meeting, please submit by October 15th.

Where to send your grant proposal

Please email your proposal in PDF format to ray@alstherapyalliance.org.

ALS Therapy Alliance Grants Program

Thank you for your interest in submitting a proposal for grant funding to the ALS Therapy Alliance (ATA). Our organization traditionally awards grants from one to three years in term ranging from $100,000 to $1 million in funding to both non- and for-profit companies. National and international companies are eligible to apply.

The following outline will help you prepare the information needed for our next funding review, which happens twice a year in April and November.

Please note grant submission deadlines and number of copies requested in order to ensure timely processing of your application. The ALS Therapy Alliance does not cover indirect costs.

If you have questions about the submission process or this application, please contact Ray Bisson, Grants Manager at (603) 664-5005 or ray@alstherapyalliance.org, or visit our FAQ page.

http://alstherapyalliance.org/index.php/research/grant-submission-process/faqs.html

What to include with your grant proposal

ATA grant applications should follow the following format and adhere strictly to the maximum page limits (using only 11 point font or greater):

■ Abstract (1 page)

■ Background and Significance (2 pages)

■ Preliminary Data (2 pages)

■ Experimental Plan (3 pages)

■ References (no limit)

■ Budget

■ Budget Justification

■ NIH Biosketch (including present and pending support, 4 pages maximum) for PI's, post-docs and others involved in the project (excluding laboratory technicians)

■ Letters of collaboration and support

Grant proposal submission deadlines

To have your grant proposal reviewed at our April meeting, please submit by March 15th. To have your grant proposal reviewed at our November meeting, please submit by October 15th.

Where to send your grant proposal

Please email your proposal in PDF format to ray@alstherapyalliance.org.

Call for Applications: Meso Foundation Research Grants

The Meso Foundation (formerly known as MARF) is the non-profit dedicated to ending the suffering caused by mesothelioma. We are the international collaboration of patients and families, physicians, advocates, and researchers dedicated to eradicating the life-ending and vicious effects of mesothelioma. We believe in a cure for meso. Given the human toll of suffering the disease causes, the compassion and energy of the meso community, the moral, legal and economic aspects of asbestos, and the benefits of meso research to cancer research generally, we believe that the resources to accomplish this cure are available and must be mobilized. We seek to marshal and utilize these resources responsibly, as effectively as possible, with financial transparency and by adhering to health policy guidelines that foster ethical clinical and administrative practices, and ethical decision making to:

·  Offer hope and support to patients and families by educating them on the disease, helping them to obtain the most up-to-date information on treatment options and to connect with meso treatment specialists, and providing them assistance, emotional support and community with others;

·  Raise awareness of meso, and advocate that the public and private sectors partner in the effort to cure it by directing the resources needed to stop this global tragedy; and

·  Fund the highest quality and most promising meso research projects from around the world through rigorous peer-review. To date we have funded 86 projects, from six different countries, totaling over 8.2 million dollars.

The Meso Foundation offers research grants for two years up to $50,000 per year. Eligible projects may relate to benchwork, translational or clinical research that is not presently funded or pending review and may be conducted through any not-for-profit academic, medical or research institution. The Foundation will review and monitor the project's progress and results, requiring semi-annual disposition of funds reports, a ten month progress report, a presentation at the Foundation’s Symposium and a full progress report at the close of the project. The Foundation seeks exceptional projects for which the Foundation's funding is demonstrated to be essential and not duplicative. Please be advised that the Foundation does not pay institutional indirect costs.

Funded researchers will also be entitled to facilitated access to the National Mesothelioma Virtual Bank (NMVB),www.mesotissue.org.They will receive expedited review of requests to use the NMVB, and they will have direct, no-cost access to materials in the bank, as well as enhanced collections from the main sites of materials.

Encouraged projects include, but are not limited to, investigations of:

1. Strategies for early detection of new or progressive disease;

2. Definition of targetable differences between normal and transformed mesothelium and development of novel strategies for treatment;

3. Therapeutic intervention, including but not limited to;

a. Immune Response Targeted Therapy

b. Novel chemotherapeutic compounds

c. Novel radiation or surgical techniques

4. Determination of clinical/molecular determinants for prognosis

Applications will be considered for funding by the Meso Foundation’s Science Advisory Board comprised of doctors and researchers who work around the world within the mesothelioma field. These members will review and score the research proposals based on the following criteria. The applications will be ranked numerically and the highest scoring projects will be recommended to the Foundation’s Board of Directors for funding. Based on the funding available, awards will be granted.

Applications will be evaluated on the following criteria:

Significance - Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?

Investigator(s)- Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?

Innovation - Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?

Approach - Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, justified in terms of the scientific goals and research strategy proposed?

Environment - Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?

Applications should be submittedthrough proposalCENTRAL.You will find the Mesothelioma Applied Research Foundation listed with the instructions and the application required. Applications are limited to 10 pages (not including biographies) and are due no later than August 2, 2013. Final award decisions will be made in December 2013 and all applicants will be notified of the outcome.

Call for Nominations: Accelerating Science Award Program

Nominate A Pioneer who has applied scientific research published through Open Access to innovate in any field.

Deadline: June 15, 2013

The Accelerating Science Award Program (ASAP) recognizes individuals who have used, applied, or remixed scientific research — published through Open Access — to make a difference in science, medicine, business, technology or society as a whole.

Three top awards of $30,000 each

A trip to Washington, D.C., to be honored at Open Access Week in October, 2013

Inclusion in a portfolio book distributed online and in print around the world

Travel Grants for the 4th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2013)

September 6 - 7, 2013 Bethesda, Maryland

This important Conference will highlight the latest scientific and clinical developments related to the management of thymic malignancies and will bring together established scientists and clinicians from all over the world who have interest in the field of thymic cancers research.

The Conference is pleased to offer travel grants to trainees, residents and fellows.

Eligible Candidates

Trainee, resident or fellow - proof of status required

Submitting and presenting author for an abstract accepted at ITMIG 2013

Benefits

Complimentary full Conference registration

Cash award to help offset travel expenses

Supporting Application Materials

Curriculum Vitae
Recommendation/Supporting Letter from supervisor
Proof of status (trainee, resident, fellow)

How to Apply?

Send application email including supporting materials to itmig2013@icsevents.com by June 14, 2013

Submit abstract via online abstract submission form by June 14, 2013

Terms and Conditions

The organizers reserve the right to

Cancel the scholarship if a selected award winner is not attending in person

Amend the terms and conditions of the scholarship program without notice

Deadlines and Timelines

Application Deadline: June 14, 2013

Notifications: expected to be available end of July 2013

Contact

For any questions or inquries regarding travel grants, please contact the Conference Secretariat at itmig2013@icsevents.com.

American Academy of Family Physicians Foundation Research Stimulation Grants

Since September 1, 2013 is on Sunday and Labor Day follows on Monday, the deadline for the second cycle of 2013 is Tuesday, September 3.

This program provides $7,500 per project to support research that poses questions of high relevance to family physicians and their patients. Applications for studies with lower costs are also welcome.

The program goals are to:

• Support research of value to the practicing physician

• Encourage proposals by junior investigators

• Fund pilot studies

Gilead Sciences Research Scholars Program in Cystic Fibrosis

Application Deadline: July 26, 2013

The mission of the Gilead Sciences Research Scholars Program in Cystic Fibrosis is to support innovative scientific research that will advance knowledge in the fields of pediatric and adult cystic fibrosis and provide support for early research career development. Gilead Sciences, Inc. hopes that the research supported by these awards will enhance understanding of cystic fibrosis.

The Program provides financial support to 3 junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years. Funding for the second year is contingent upon submission of a progress report and approval by the Scientific Review Committee Chair.

Recipients of these competitive awards will be selected by a Committee comprised of leaders in the field of cystic fibrosis (the "Scientific Review Committee" or the "Committee"). The Committee will review complete applications and select research proposals based on their scientific merit, feasibility, mentorship, environment, and candidate. Announcement of award recipients will be made at an awards dinner hosted by the Committee and senior representatives from Gilead.

Applicants must meet the eligibility criteria in order to be considered for an award.

Eligibility

This award is intended for junior faculty who are in the early stages of their career; specifically, the Applicant may be the recipient of a career development (K) award, or another mentored research award, but not an RO1 grant or equivalent.

Applicants must meet the following requirements:

Hold an MD, DO, PhD, or equivalent degree at time of award

Be within 7 years of a faculty appointment, or an assistant professor, in association with a research institution in the United States at the time of application

Have a strong career interest in cystic fibrosis

Have a research mentor with extensive experience in the field of cystic fibrosis

Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)

Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects

Citizenship

An Applicant must be a citizen or permanent resident of the United States or hold a temporary nonimmigrant visa. This visa must be valid for the two-year award period (January 2, 2014 – December 31, 2015).

For general inquires about the Research Scholars Program, please call or email:

Gilead Sciences Research Scholars Program in Cystic Fibrosis

Attn: Research Scholars Program Coordinator

Telephone: 646-674-1820
Email: cfresearchscholars@contacthmc.com

If you are experiencing technical difficulties, please contact Zoomedia at 901-210-9564. If you have any other questions, please contact the Research Scholars Program Coordinator at 646-474-1820.

Peter F. Drucker Award for Nonprofit Innovation

The Peter F. Drucker Award for Nonprofit Innovation is given each fall to a nonprofit organization that best demonstrates Druckerʼs definition of innovation: “change that creates a new dimension of performance.” The award has been given annually since 1991 and is accompanied by a first-place prize of $100,000. The program is generously supported by The Coca-Cola Foundation.

The purpose of the annual Peter F. Drucker Award for Nonprofit Innovation is to find the innovators, whether small or large; to recognize and celebrate their example; and to inspire others.

The completed application must be submitted by 3pm PT on July 1, 2013.